{"id":22343,"date":"2026-07-24T22:30:00","date_gmt":"2026-07-24T20:30:00","guid":{"rendered":"https:\/\/www.sequanamedical.com\/?p=22343"},"modified":"2026-07-24T22:08:49","modified_gmt":"2026-07-24T20:08:49","slug":"sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent","status":"publish","type":"post","link":"https:\/\/www.sequanamedical.com\/nl\/persberichten\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/","title":{"rendered":"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT"},"content":{"rendered":"\n

Gent,<\/ins> Belgi\u00eb, 24 juli 2026 \u2013 SEQUANA MEDICAL NV (Euronext Brussel: SEQUA) (de “Vennootschap” of “Sequana Medical”) <\/strong>en haar volledige dochteronderneming DSRCo BV zijn bij vonnis van de Ondernemingsrechtbank Gent van 30 juni 2026 failliet verklaard.<\/p>\n\n\n\n

SEQUANA MEDICAL NV was actief in de ontwikkeling van innovatieve medische technologie\u00ebn voor de behandeling van pati\u00ebnten met ernstige vochtoverbelasting. De onderneming ontwikkelde onder meer de alfa<\/strong>pump\u00ae, een implanteerbaar medisch hulpmiddel voor pati\u00ebnten met leverascites, en de DSR\u00ae therapie (Direct Sodium Removal), een technologie gericht op de behandeling van vochtretentie bij hartfalen.<\/p>\n\n\n\n

Op het ogenblik van het faillissement stelde de groep in totaal 43 werknemers te werk. Vier werknemers waren actief op de maatschappelijke zetel in Gent, terwijl vijfendertig werknemers waren tewerkgesteld in het bijkantoor in Z\u00fcrich (Zwitserland), waar de assemblage van de alfa<\/strong>pump\u00ae\u00a0<\/del>plaatsvond. Daarnaast werden de commerci\u00eble activiteiten in de Verenigde Staten gevoerd via de dochtervennootschap SEQUANA MEDICAL US INC, waar vier medewerkers werkzaam waren. <\/p>\n\n\n\n

De door de rechtbank aangestelde curatoren onderzoeken momenteel alle mogelijkheden om de activiteiten, technologie\u00ebn en activa binnen een continu\u00efteits- of overnamekader te valoriseren. Daarbij wordt bijzondere aandacht besteed aan de belangen van de pati\u00ebnten die afhankelijk zijn van de ontwikkelde technologie\u00ebn, de werknemers, de schuldeisers en de talrijke particuliere en institutionele investeerders en beleggers.<\/p>\n\n\n\n

Het aandeel van SEQUANA MEDICAL NV blijft voorlopig geschorst van verhandeling op Euronext Brussel. Naar verwachting zal deze schorsing minstens aanhouden tot na de afsluiting van de faillissementsprocedure.<\/p>\n\n\n\n

Meer informatie over de\u00a0Overname-opportuniteit \u2013 ALFAPUMP\u00ae- en DSR\u00ae-activa via\u00a0https:\/\/www.sequanamedical.com\/nl\/investeerders\/informatie-voor-aandeelhouders\/<\/a><\/p>\n\n\n\n

Voor meer informatie, neem contact op met:<\/strong><\/p>\n\n\n\n

Catharina Janssens & Lisa Heuninck<\/p>\n\n\n\n

Curatoren SEQUANA MEDICAL NV & DSRCO BV<\/p>\n\n\n\n

E: catharina.janssens@bloom-law.be<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Gent, Belgi\u00eb, 24 juli 2026 \u2013 SEQUANA MEDICAL NV (Euronext Brussel: SEQUA) (de “Vennootschap” of “Sequana Medical”) en haar volledige dochteronderneming DSRCo BV zijn bij vonnis van de Ondernemingsrechtbank Gent van 30 juni 2026 failliet verklaard. SEQUANA MEDICAL NV was actief in de ontwikkeling van innovatieve medische technologie\u00ebn voor de behandeling van pati\u00ebnten met ernstige […]<\/p>\n","protected":false},"author":25,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[74],"tags":[],"class_list":["post-22343","post","type-post","status-publish","format-standard","hentry","category-persberichten"],"acf":[],"yoast_head":"\nSEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical\" \/>\n<meta property=\"og:description\" content=\"Gent, Belgi\u00eb, 24 juli 2026 \u2013 SEQUANA MEDICAL NV (Euronext Brussel: SEQUA) (de “Vennootschap” of “Sequana Medical”) en haar volledige dochteronderneming DSRCo BV zijn bij vonnis van de Ondernemingsrechtbank Gent van 30 juni 2026 failliet verklaard. SEQUANA MEDICAL NV was actief in de ontwikkeling van innovatieve medische technologie\u00ebn voor de behandeling van pati\u00ebnten met ernstige […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/\" \/>\n<meta property=\"og:site_name\" content=\"Sequana Medical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/alfapump\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-24T20:30:00+00:00\" \/>\n<meta name=\"author\" content=\"Nathalie Degeyter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SequanaMed\" \/>\n<meta name=\"twitter:site\" content=\"@SequanaMed\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/\"},\"author\":{\"name\":\"Nathalie Degeyter\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#\\\/schema\\\/person\\\/8a186323b6228de061031b80ae8a2885\"},\"headline\":\"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT\",\"datePublished\":\"2026-07-24T20:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/\"},\"wordCount\":293,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#organization\"},\"articleSection\":[\"Persberichten\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/\",\"url\":\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/\",\"name\":\"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#website\"},\"datePublished\":\"2026-07-24T20:30:00+00:00\",\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sequanamedical.com\\\/nl\\\/press-releases\\\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#website\",\"url\":\"https:\\\/\\\/www.sequanamedical.com\\\/\",\"name\":\"Sequana Medical\",\"description\":\"Pioneer in the treatment of fluid overload\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sequanamedical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#organization\",\"name\":\"Sequana Medical NV\",\"url\":\"https:\\\/\\\/www.sequanamedical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sequanamedical.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/Sequana-medical_logo.png\",\"contentUrl\":\"https:\\\/\\\/www.sequanamedical.com\\\/wp-content\\\/uploads\\\/2017\\\/09\\\/Sequana-medical_logo.png\",\"width\":396,\"height\":70,\"caption\":\"Sequana Medical NV\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/alfapump\",\"https:\\\/\\\/x.com\\\/SequanaMed\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sequana-medical\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sequanamedical.com\\\/#\\\/schema\\\/person\\\/8a186323b6228de061031b80ae8a2885\",\"name\":\"Nathalie Degeyter\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g\",\"caption\":\"Nathalie Degeyter\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/","og_locale":"nl_NL","og_type":"article","og_title":"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical","og_description":"Gent, Belgi\u00eb, 24 juli 2026 \u2013 SEQUANA MEDICAL NV (Euronext Brussel: SEQUA) (de “Vennootschap” of “Sequana Medical”) en haar volledige dochteronderneming DSRCo BV zijn bij vonnis van de Ondernemingsrechtbank Gent van 30 juni 2026 failliet verklaard. SEQUANA MEDICAL NV was actief in de ontwikkeling van innovatieve medische technologie\u00ebn voor de behandeling van pati\u00ebnten met ernstige […]","og_url":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/","og_site_name":"Sequana Medical","article_publisher":"https:\/\/www.facebook.com\/alfapump","article_published_time":"2026-07-24T20:30:00+00:00","author":"Nathalie Degeyter","twitter_card":"summary_large_image","twitter_creator":"@SequanaMed","twitter_site":"@SequanaMed","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/#article","isPartOf":{"@id":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/"},"author":{"name":"Nathalie Degeyter","@id":"https:\/\/www.sequanamedical.com\/#\/schema\/person\/8a186323b6228de061031b80ae8a2885"},"headline":"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT","datePublished":"2026-07-24T20:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/"},"wordCount":293,"publisher":{"@id":"https:\/\/www.sequanamedical.com\/#organization"},"articleSection":["Persberichten"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/","url":"https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/","name":"SEQUANA MEDICAL NV EN DOCHTERONDERNEMING DSRCo BV FAILLIET VERKLAARD DOOR DE ONDERNEMINGSRECHTBANK GENT - Sequana Medical","isPartOf":{"@id":"https:\/\/www.sequanamedical.com\/#website"},"datePublished":"2026-07-24T20:30:00+00:00","inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sequanamedical.com\/nl\/press-releases\/sequana-medical-nv-en-dochteronderneming-dsrco-bv-failliet-verklaard-door-de-ondernemingsrechtbank-gent\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.sequanamedical.com\/#website","url":"https:\/\/www.sequanamedical.com\/","name":"Sequana Medical","description":"Pioneer in the treatment of fluid overload","publisher":{"@id":"https:\/\/www.sequanamedical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sequanamedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.sequanamedical.com\/#organization","name":"Sequana Medical NV","url":"https:\/\/www.sequanamedical.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.sequanamedical.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.sequanamedical.com\/wp-content\/uploads\/2017\/09\/Sequana-medical_logo.png","contentUrl":"https:\/\/www.sequanamedical.com\/wp-content\/uploads\/2017\/09\/Sequana-medical_logo.png","width":396,"height":70,"caption":"Sequana Medical NV"},"image":{"@id":"https:\/\/www.sequanamedical.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/alfapump","https:\/\/x.com\/SequanaMed","https:\/\/www.linkedin.com\/company\/sequana-medical"]},{"@type":"Person","@id":"https:\/\/www.sequanamedical.com\/#\/schema\/person\/8a186323b6228de061031b80ae8a2885","name":"Nathalie Degeyter","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/46e626dbfdd9cbd414d7bc757b9f7e0d1e590b611c930adc88f76d38b7b4f885?s=96&d=mm&r=g","caption":"Nathalie Degeyter"}}]}},"_links":{"self":[{"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/posts\/22343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/comments?post=22343"}],"version-history":[{"count":2,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/posts\/22343\/revisions"}],"predecessor-version":[{"id":22345,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/posts\/22343\/revisions\/22345"}],"wp:attachment":[{"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/media?parent=22343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/categories?post=22343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sequanamedical.com\/nl\/wp-json\/wp\/v2\/tags?post=22343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}